These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 12009270)
41. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease. Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368 [TBL] [Abstract][Full Text] [Related]
42. Development of pneumococcal polysaccharide conjugate vaccine with long spacer arm. Wu D; Ji S; Hu T Vaccine; 2013 Nov; 31(48):5623-6. PubMed ID: 24120485 [TBL] [Abstract][Full Text] [Related]
43. Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice. Jansen WT; Hogenboom S; Thijssen MJ; Kamerling JP; Vliegenthart JF; Verhoef J; Snippe H; Verheul AF Infect Immun; 2001 Feb; 69(2):787-93. PubMed ID: 11159969 [TBL] [Abstract][Full Text] [Related]
44. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848 [TBL] [Abstract][Full Text] [Related]
45. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. Käyhty H; Ahman H; Rönnberg PR; Tillikainen R; Eskola J J Infect Dis; 1995 Nov; 172(5):1273-8. PubMed ID: 7594664 [TBL] [Abstract][Full Text] [Related]
46. Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model. Skinner JM; Indrawati L; Cannon J; Blue J; Winters M; Macnair J; Pujar N; Manger W; Zhang Y; Antonello J; Shiver J; Caulfield M; Heinrichs JH Vaccine; 2011 Nov; 29(48):8870-6. PubMed ID: 21964055 [TBL] [Abstract][Full Text] [Related]
47. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia. Sherwin RL; Gray S; Alexander R; McGovern PC; Graepel J; Pride MW; Purdy J; Paradiso P; File TM J Infect Dis; 2013 Dec; 208(11):1813-20. PubMed ID: 24092845 [TBL] [Abstract][Full Text] [Related]
48. Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid. Amir-Kroll H; Nussbaum G; Cohen IR J Immunol; 2003 Jun; 170(12):6165-71. PubMed ID: 12794147 [TBL] [Abstract][Full Text] [Related]
49. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier protein. Kamboj KK; Kirchner HL; Kimmel R; Greenspan NS; Schreiber JR J Infect Dis; 2003 May; 187(10):1629-38. PubMed ID: 12721943 [TBL] [Abstract][Full Text] [Related]
50. Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae. Rauly I; Goetsch L; Haeuw JF; Tardieux C; Baussant T; Bonnefoy JY; Corvaia N Infect Immun; 1999 Nov; 67(11):5547-51. PubMed ID: 10531198 [TBL] [Abstract][Full Text] [Related]
51. The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination. Rabquer B; Smithson SL; Shriner A; Julie Westerink MA Immunol Lett; 2006 Aug; 106(2):187-90. PubMed ID: 16781780 [TBL] [Abstract][Full Text] [Related]
52. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. Väkeväinen M; Eklund C; Eskola J; Käyhty H J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443 [TBL] [Abstract][Full Text] [Related]
54. Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants. Yeh SH; Zangwill KM; Lee H; Chang SJ; Wong VI; Greenberg DP; Ward JI Vaccine; 2003 Jun; 21(19-20):2627-31. PubMed ID: 12744899 [TBL] [Abstract][Full Text] [Related]
55. The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine. Wei D; Yu W; Hu C; Shen L; Hu T Biotechnol Lett; 2018 Aug; 40(8):1263-1270. PubMed ID: 29802568 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of humoral response to heptavalent pneumococcal conjugate vaccine in HIV-infected children. Costa Ide C; Guilardi F; Kmiliauskis MA; Arslanian C; Baldacci ER Rev Saude Publica; 2008 Oct; 42(5):844-50. PubMed ID: 18797574 [TBL] [Abstract][Full Text] [Related]